Lcnb Corp Bristol Myers Squibb CO Transaction History

Lcnb Corp

$275 Million
Q1 2024

A detailed history of Lcnb Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lcnb Corp holds 5,211 shares of BMY stock, worth $214,276. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,211

Previous 5,819 10.45%

Holding current value

$214,276

Previous $298,000 5.37%

% of portfolio

0.1%

Previous 0.12%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $29,171 - $33,075	-608 Reduced 10.45%	5,211 $282,000
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $4,314 - $5,148	-89 Reduced 1.51%	5,819 $298,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $78,325 - $87,579	-1,353 Reduced 18.63%	5,908 $342,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $82,886 - $92,032	-1,301 Reduced 15.2%	7,261 $464,000
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $6,848 - $8,109	100 Added 1.18%	8,562 $615,000

Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $40 - $23,974	-312 Reduced 3.56%	8,462 $602,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1,984 - $2,313	-37 Reduced 0.42%	8,774 $547,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $15,384 - $18,020	-260 Reduced 2.87%	8,811 $521,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $6,191 - $6,742	100 Added 1.11%	9,071 $606,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $30,263 - $34,037	-510 Reduced 5.38%	8,971 $566,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $1,154 - $1,308	-20 Reduced 0.21%	9,481 $588,000
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $29,289 - $32,456	-510 Reduced 5.09%	9,501 $573,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $4,083 - $5,933	88 Added 0.89%	10,011 $558,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $81,540 - $106,362	1,657 Added 20.05%	9,923 $637,000
Q3 2019 Nov 08, 2019	BUY	$42.77 - $50.71 $40,588 - $48,123	949 Added 12.97%	8,266 $419,000
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $44 - $49	-1 Reduced 0.01%	7,317 $332,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $6,542 - $7,801	-145 Reduced 1.94%	7,318 $349,000
Q4 2018 Feb 19, 2019	BUY	$48.76 - $63.23 $13,409 - $17,388	275 Added 3.83%	7,463 $388,000
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $4,415 - $4,980	-80 Reduced 1.1%	7,188 $446,000
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $143,656 - $179,052	2,843 Added 64.25%	7,268 $402,000
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $22,290 - $25,660	372 Added 9.18%	4,425 $280,000
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $30,809 - $33,589	-514 Reduced 11.25%	4,053 $248,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $1,822 - $2,103	33 Added 0.73%	4,567 $292,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,534	4,534 $253,000

Others Institutions Holding BMY

# of Institutions

2,557

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lcnb Corp with notifications on news.

Account